Table of Content

Table of Contents

Global Polypeptide Drug Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Polypeptide Drug Market by Value
2.2.1 Global Polypeptide Drug Revenue by Type
2.2.2 Global Polypeptide Drug Market by Value (%)
2.3 Global Polypeptide Drug Market by Production
2.3.1 Global Polypeptide Drug Production by Type
2.3.2 Global Polypeptide Drug Market by Production (%)

3. The Major Driver of Polypeptide Drug Industry
3.1 Historical & Forecast Global Polypeptide Drug Demand
3.2 Largest Application for Polypeptide Drug (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Polypeptide Drug Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Polypeptide Drug Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Polypeptide Drug Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Polypeptide Drug Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Polypeptide Drug Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Polypeptide Drug Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Polypeptide Drug Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Polypeptide Drug Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Polypeptide Drug Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Polypeptide Drug Average Price Trend
12.1 Market Price for Each Type of Polypeptide Drug in US (2018-2022)
12.2 Market Price for Each Type of Polypeptide Drug in Europe (2018-2022)
12.3 Market Price for Each Type of Polypeptide Drug in China (2018-2022)
12.4 Market Price for Each Type of Polypeptide Drug in Japan (2018-2022)
12.5 Market Price for Each Type of Polypeptide Drug in India (2018-2022)
12.6 Market Price for Each Type of Polypeptide Drug in Korea (2018-2022)
12.7 Market Price for Each Type of Polypeptide Drug in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Polypeptide Drug Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Polypeptide Drug

14. Polypeptide Drug Competitive Landscape
14.1 Novartis
14.1.1 Novartis Company Profiles
14.1.2 Novartis Product Introduction
14.1.3 Novartis Polypeptide Drug Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck Serono
14.2.1 Merck Serono Company Profiles
14.2.2 Merck Serono Product Introduction
14.2.3 Merck Serono Polypeptide Drug Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Ferring Pharmaceuticals
14.3.1 Ferring Pharmaceuticals Company Profiles
14.3.2 Ferring Pharmaceuticals Product Introduction
14.3.3 Ferring Pharmaceuticals Polypeptide Drug Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Ipsen PHarma Biotech
14.4.1 Ipsen PHarma Biotech Company Profiles
14.4.2 Ipsen PHarma Biotech Product Introduction
14.4.3 Ipsen PHarma Biotech Polypeptide Drug Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Lilly
14.5.1 Lilly Company Profiles
14.5.2 Lilly Product Introduction
14.5.3 Lilly Polypeptide Drug Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Asahi Kasei
14.6.1 Asahi Kasei Company Profiles
14.6.2 Asahi Kasei Product Introduction
14.6.3 Asahi Kasei Polypeptide Drug Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 AstraZeneca
14.7.1 AstraZeneca Company Profiles
14.7.2 AstraZeneca Product Introduction
14.7.3 AstraZeneca Polypeptide Drug Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 SciClone Pharmaceuticals
14.8.1 SciClone Pharmaceuticals Company Profiles
14.8.2 SciClone Pharmaceuticals Product Introduction
14.8.3 SciClone Pharmaceuticals Polypeptide Drug Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Takeda
14.9.1 Takeda Company Profiles
14.9.2 Takeda Product Introduction
14.9.3 Takeda Polypeptide Drug Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Roche
14.10.1 Roche Company Profiles
14.10.2 Roche Product Introduction
14.10.3 Roche Polypeptide Drug Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Sanofi
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Polypeptide Drug Industry (Volume)
Figure 2. Polypeptide Drug Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Polypeptide Drug Revenue in 2022
Figure 5. US Polypeptide Drug Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Polypeptide Drug Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Polypeptide Drug Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Polypeptide Drug Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Polypeptide Drug Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Polypeptide Drug Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Polypeptide Drug Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Polypeptide Drug Revenue, by Type (Million USD) (2018-2028)
Table 4. Polypeptide Drug Production, by Type (K Unit) (2018-2028)
Table 5. Polypeptide Drug Demand (K Unit) by Application (2018-2028)
Table 6. Polypeptide Drug Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Polypeptide Drug Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Polypeptide Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Polypeptide Drug in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Polypeptide Drug in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Polypeptide Drug in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Polypeptide Drug in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Polypeptide Drug in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Polypeptide Drug in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Polypeptide Drug in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Novartis Profiles
Table 61. Novartis Polypeptide Drug Product Introduction
Table 62. Novartis Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Novartis Strategic initiatives
Table 64. Merck Serono Profiles
Table 65. Merck Serono Polypeptide Drug Product Introduction
Table 66. Merck Serono Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck Serono Strategic initiatives
Table 68. Ferring Pharmaceuticals Profiles
Table 69. Ferring Pharmaceuticals Polypeptide Drug Product Introduction
Table 70. Ferring Pharmaceuticals Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Ferring Pharmaceuticals Strategic initiatives
Table 72. Ipsen PHarma Biotech Profiles
Table 73. Ipsen PHarma Biotech Polypeptide Drug Product Introduction
Table 74. Ipsen PHarma Biotech Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Ipsen PHarma Biotech Strategic initiatives
Table 76. Lilly Profiles
Table 77. Lilly Polypeptide Drug Product Introduction
Table 78. Lilly Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Lilly Strategic initiatives
Table 80. Asahi Kasei Profiles
Table 81. Asahi Kasei Polypeptide Drug Product Introduction
Table 82. Asahi Kasei Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Asahi Kasei Strategic initiatives
Table 84. AstraZeneca Profiles
Table 85. AstraZeneca Polypeptide Drug Product Introduction
Table 86. AstraZeneca Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. AstraZeneca Strategic initiatives
Table 88. SciClone Pharmaceuticals Profiles
Table 89. SciClone Pharmaceuticals Polypeptide Drug Product Introduction
Table 90. SciClone Pharmaceuticals Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. SciClone Pharmaceuticals Strategic initiatives
Table 92. Takeda Profiles
Table 93. Takeda Polypeptide Drug Product Introduction
Table 94. Takeda Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Takeda Strategic initiatives
Table 97. Roche Profiles
Table 98. Roche Polypeptide Drug Product Introduction
Table 99. Roche Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Roche Strategic initiatives
Table 101. Sanofi Profiles
Table 102. Sanofi Polypeptide Drug Product Introduction
Table 103. Sanofi Polypeptide Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Sanofi Strategic initiatives